Elizabeth Eisenhauer, Professor Emerita at Queen’s University, shared a post on LinkedIn:
“As 3 cancer trials groups with a history of international collaboration the CCTG, EORTC and UK3CR welcome the G7 leaders statement on committing to accelerating cancer research.
In particular we underscore how critical stable investment in independent academic cancer trials are to translating advances into patient care.
Read full statement here: CCTG, EORTC and UK3CR welcome G7 commitment to accelerate global progress against cancer.”
Other articles featuring Elizabeth Eisenhauer on OncoDaily.